close
Add to watchlist
Kensey Nash Corp (KNSY) Healthcare, Medical Equipment & Supplies
Kensey Nash Corporation, a medical device company, develops products and technologies in the fields of biomaterials and endovascular devices used in various medical procedures and endovascular devices. It designs, develops, manufactures, and processes biomaterials products, such as resorbable polymer and collagen products for various applications, including orthopaedic, cardiology, drug/biologics delivery, periodontal, general surgery, and wound care. The company manufactures Angio-Seal components; orthopaedic products for various applications of biomaterials, which include soft tissue and bone fixation, bone void fillers, and scaffolds; and biomaterials-based products, including resorbable breast biopsy markers, dental barrier membranes, and wound care products designed for other market applications. It also designs, manufactures, markets, and sells thrombectomy and chronic total occlusion (CTO) devices. These products include ThromCat Thrombectomy Catheter System, QuickCat Extraction Catheter, and Safe-Cross radio frequency CTO system to remove thrombus (blood clots) from the patient during interventional procedures. The company sells its products through direct sales force primarily in the United States and Germany, as well as through distributors in Europe, Russia, and India. Kensey Nash has partnership with Orthovita, Inc. to develop and commercialize Vitoss Foam and Vitoss Pack based on Orthovita's proprietary Vitoss bone graft substitute material in combination with the company's proprietary biomaterials. The company was founded in 1984 and is headquartered in Exton, Pennsylvania.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 24.33 |
| Volume | 12544 |
| Volume Avg | 45939 |
| 52 Week High | 29.39 |
| 52 Week Low | 18.17 |
| PE | 144.73 |
| PE (group average) | 39 |
| EPS Year | 0.17 |
| EPS change Q/Q | 1000% |
| EPS change Q/Q Yr ago | 1000% |
| EPS change Q/Q next Q est | 1000% |
| EPS change Y/Y | 238.78% |
| REV change Q/Q | 6.9% |
| REV change Q/Q Yr ago | -6.53% |
| EPS next Q est | 0.26 |
| EPS next Y est | 1.69 |
| Divident Annual | 0.25 |
| Dividend Yield | 1.03% |